CD8A and breast cancer: Here, we performed an exploratory analysis to examine the prognostic impact of CSF-1R+ carcinoma cells in the context of iTIL subsets expressing CD8 or FOXP3 in ER-positive breast cancers in the combined cohort of the BC Cancer series with complete 20-year follow-up information (n = 1666).